New Article Featuring Our CEO Eric Halioua Published in BioProcess International
We are thrilled to announce that BioProcess International, a leading global platform for the bioprocessing industry, has published a new article featuring an interview with our CEO, Eric Halioua. In this piece, Eric shares the remarkable journey of PDC*line Pharma, from its founding to its latest advancements in cancer immunotherapy.
The interview provides valuable insights into the driving force behind our innovative platform, the resilience required to thrive in the biotech industry, and the transformative role of global partnerships in our success.
You can read the full article by clicking the link below:
/sites/default/files/images/Eric_Halioua_Article%20Bioprocess%2002%2011%202024.pdf
About BioProcess International:
BioProcess International™ is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process.
BPI is a business unit of Informa Connect https://informaconnect.com
